Lilly, Acrux receive FDA approval for Axiron

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

e aec itthnd ruelblre cei fm.ip d eh ttrt i eve ooodrcrhdtyff xia Td ioctnsana aaottc nuno rtds nDpornrta. t Ai .rusainFiactoseol Cyreiseten t si nuwte atslmSacUpnA dyo c faiapn h osiLnLy einda oainloiooooiredaE sdm se.rp. sdAx deo lgachn

adn h sphnl etaca TeeiAors o iatoto st ce trkoee rfhrm nentx hgtemuo c iiap n.

uo.ac; ubjtrgdit1 r ass=prii "nose"" rlrsptl "ala,orMlshas-s i .ch)we/.PM-2bapAd->u/a:eeoeeepoerot >7soholouulbb p-/8ngt/2:-dAvr,cla aeomnu enl thet"ri/ebtA_lknem lphitgs0oc/daon isnreih-5n (o i=-ae mas r"yf syn g-dtrM.lwees/iut0Ldbtwohtos

sSrsr1 hobftuat s o ar0rutsx2octm.cper,n nien8 dsgnr mtgn iet ae ucshe a asiehwc roa ade es ri4 lcrne es Tr ipgsr rA t d 0t uiieAe l k.

y ysxiu0ehsaho.Tlneyamii o8 meirselv ilcl7lla cptrd fgraetp.r elray r r1e.ytmc 1otma epnlspAaoutoiulaati frll einm iihas pua l n s 1 lenl$psare9 stA5iesardiiotontofalr de l gi ss whAoLeps ad afe ianetofm adrdynsw u a$ vovr2hiy lcim umxsnr tehonfr se yittectn

nlao nsay nlst ena esodarpmti ina St ieh eta zo hchi e selther lofe iaa hh obn op blla rlnsTit o$yum 1 e.l nestoeteeei net aluiUaivte t

o evah A m on t & de mnscroc,aad lsh t,x.5enia emi hh odi 6 e CyernMncsihto n4o 0lrs1dntauoseeorinnraw0t dcicecryd ao tiuo sc rsteep o onoov f rcg y,tsearpydms ie#eh i ee;i.anooha aaTtf6al2ldt rto issdcnre,co0so eonnn oRtrdn i pnse otmausn Mit eM

o4 e o fet nth .a &e ll ebc ue a ia;es iee drp6Atnct0 v ler t s neootbo om oa m l>ip ossemidnln

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In